LUNG CANCER STAGE III
Clinical trials for LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may make inoperable lung cancer removable
Disease control Recruiting nowThis study tests whether giving a combination of drugs (IBI308, bevacizumab, pemetrexed, and carboplatin) before surgery can shrink stage III non-small cell lung cancer enough to allow surgical removal. The goal is to see how many people can then have surgery. The study includes …
Matched conditions: LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for hard-to-treat lung cancer: targeted drugs before surgery
Disease control Recruiting nowThis study tests whether giving targeted drugs before surgery can help people with stage III lung cancer that has rare gene changes. About 120 adults who have not had treatment will receive a drug matched to their tumor's mutation, then doctors will check if the tumor becomes rem…
Matched conditions: LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could an arthritis drug boost chemo for lung cancer?
Disease control Recruiting nowThis study tests whether adding certolizumab (an anti-inflammatory drug) to standard chemotherapy and immunotherapy helps shrink stage II-III lung cancer more effectively before surgery. About 60 adults with operable lung cancer will receive the combination, then have their tumor…
Matched conditions: LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC